Sign in
CompletedNo phase

Volume Kinetics of Fluid Resuscitation in Early Sepsis

Key facts

Who runs it
Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu
Where
Romania2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
13 people enrolled
Started
19 Jun 2024
Ended
1 Oct 2026
Type of study
Observational
Treatments tested
  • Ringer's Lactate
Record updated
20 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • A diagnosis of sepsis, as defined by the Sepsis-3 criteria and exhibiting sepsis-induced hypoperfusion prior to the administration of adequate volume resuscitation:
  • hypotension requiring norepinephrine to maintain a mean arterial blood pressure (MAP) either predefined by the clinician or at 65 mm Hg or higher and/or
  • a serum lactate level >2 mmol/L (18mg/dL) and/or
  • acute oliguria defined as urine output <0.5mL/kg/hr and/or
  • mottled skin and/or
  • capillary refill time > 3 seconds

Who cannot take part

  • Administration of at least 1 L of IV fluid in the last 6 hours prior to screening. All crystalloids, colloids and blood products that the patient has received are counted
  • Concurrent haemorrhagic or obstructive shock
  • Competing causes of lactic acidosis including: seizures within 3 hours of enrollment, use of linezolid or metformin or anti-retrovirals at the time of enrollment, carbon monoxide or cyanide poisoning, highly suspected or known ischemic bowel, and known mitochondrial disorders
  • End-stage renal disease that requires chronic dialysis
  • Increased risk of fluid intolerance:; Echocardiographic evidence of moderate or severe left ventricular systolic dysfunction; Echocardiographic evidence of moderate or severe right ventricular systolic dysfunction; Hypoxemia index < 200 mmHg or sonographic evidence of bilateral B or C profile; Abdominal compartment syndrome
  • Post-cardiac arrest
  • Known pregnancy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The recommended volume resuscitation for patients with early sepsis-induced hypoperfusion is at least 30 ml/kg of crystalloid administered within the first three hours. However, this standardized approach does not account for individual patient variability and lacks personalization. Additionally, the effects of administering 30 ml/kg on intercompartmental fluid shifts between the plasma and interstitial compartments remain unclear. This study aims to describe the volume kinetics of administering 30 ml/kg of Ringer's Lactate in patients with early sepsis-induced hypoperfusion within the first three hours.

The group in the trial

  • Ringer's Lactate

    Adult patients admitted in the intensive care unit (ICU) with sepsis, as defined by the Sepsis-3 criteria and exhibiting sepsis-induced hypoperfusion prior to the administration of adequate volume resuscitation (i.e., 30 ml/kg crystalloid).

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Volume Kinetics of Fluid Resuscitation With 30 ml/kg Ringer Lactate in Early Sepsis
Record updated
20 October 2026